Purging with rituximab in vivo combined with autologous peripheral blood stem cell transplantation for aggressive B-cell lymphoma: clinical analysis of 26 cases.
10.3760/cma.j.issn.0253-2727.2013.12.015
- Author:
Chen ZHANG
1
;
Xiao-pei WANG
;
Zhi-tao YING
;
Ling-yan PING
;
Wen ZHENG
;
Yan XIE
;
Ning-jing LIN
;
Wei-ping LIU
;
Li-juan DENG
;
Yu-qin SONG
;
Jun ZHU
Author Information
1. Peking University Cancer Hospital & Institute, Department of Lymphoma, Key Laboratory of Carcinogenesis & Translational Research Ministry of Education, Beijing 100142, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Antibodies, Monoclonal, Murine-Derived;
therapeutic use;
Bone Marrow Purging;
Female;
Humans;
Lymphoma, B-Cell;
therapy;
Male;
Middle Aged;
Peripheral Blood Stem Cell Transplantation;
Retrospective Studies;
Rituximab;
Transplantation, Autologous;
Treatment Outcome;
Young Adult
- From:
Chinese Journal of Hematology
2013;34(12):1063-1065
- CountryChina
- Language:Chinese
